India Molecular Diagnostics Market to Grow with a CAGR of 7.12% through 2030

Increasing demand for point-of-care diagnostics and rapid technological advancements is expected to drive the India Molecular Diagnostics Market growth in the forecast period, 2026-2030.

According to TechSci Research report, “India Molecular Diagnostics Market - By Region, Competition, Forecast & Opportunities, 2030”, India Molecular Diagnostics Market was valued at USD 941.24 Million in 2024 and is expected to reach USD 1413,74 Million by 2030, growing at a CAGR of 7.12% during the forecast period. Several factors are driving the growth of the Molecular Diagnostics Market in India. The increasing prevalence of infectious diseases and genetic disorders, rising awareness and acceptance of personalized medicine and companion diagnostics, and advancements in molecular techniques are some primary factors.

The improvements in healthcare infrastructure, coupled with increased healthcare expenditure and growing demand for early and accurate disease diagnosis, are also stimulating market growth. Lastly, government initiatives for the promotion of precision medicine and genetic testing is a crucial contributing factor.

The Indian Molecular Diagnostics Market is witnessing rapid growth, outpacing the global average compound annual growth rate (CAGR). This growth is driven by multiple factors, including the rising prevalence of infectious diseases, growing awareness of personalized medicine, and significant advancements in molecular techniques. Key market segments are contributing to this expansion. The infectious diseases segment leads due to the high burden of such diseases in India, necessitating timely and precise diagnosis. Meanwhile, the oncology segment is projected to grow significantly in the coming years, owing to rising cancer incidence and the increasing need for early detection and treatment.

A major factor fueling the market is the adoption of advanced molecular diagnostic technologies. Innovations like next-generation sequencing and polymerase chain reaction (PCR) have transformed diagnostics, offering enhanced speed and accuracy. The advent of point-of-care diagnostics has improved accessibility, further propelling market growth. Investment in healthcare infrastructure and research also supports expansion. Government initiatives to strengthen healthcare services, along with private sector contributions to R&D, have fostered a favorable growth environment. However, challenges remain. High testing costs and a shortage of trained professionals hinder widespread adoption. Nonetheless, initiatives are being taken to train medical staff and make diagnostics more affordable. The Indian Molecular Diagnostics Market is set for strong growth, powered by rising disease incidence, technological progress, and greater investment in healthcare. Though challenges exist, the market presents substantial opportunities for innovation and expansion in the years ahead.               

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "India Molecular Diagnostics Market”

The India Molecular Diagnostics Market is segmented into application, technology, end user, regional distribution, and company.

Based on end user, The hospital segment has emerged as the fastest-growing end-user segment in India’s Molecular Diagnostics Market, driven by their role as the primary point of care for patients seeking medical assistance. Hospitals handle a wide spectrum of medical conditions, which fuels the demand for molecular diagnostics to ensure accurate and timely diagnosis. Large hospitals, in particular, possess the financial strength and infrastructure to invest in advanced diagnostic technologies, allowing them to stay ahead in adopting cutting-edge solutions. This enables healthcare providers to deliver precise diagnostic results and improve treatment outcomes. Moreover, the rising prevalence of infectious diseases and the impact of the ongoing pandemic have highlighted the critical need for rapid, reliable testing within hospital environments. Their ability to swiftly detect and manage outbreaks has positioned hospitals as indispensable in safeguarding patient and healthcare worker safety. With their expanding diagnostic capabilities, growing patient base, and increasing reliance on molecular testing, hospitals are expected to sustain their momentum as the fastest-growing segment in India’s Molecular Diagnostics Market.

Based on region, the fastest growing region in the India molecular diagnostics market is South India. This growth is driven by a combination of factors, including robust healthcare infrastructure, a high concentration of advanced medical facilities, and the presence of leading diagnostic and biotechnology companies. Cities such as Bengaluru, Chennai, and Hyderabad have emerged as hubs for healthcare innovation and research, creating a favorable environment for the adoption of molecular diagnostic technologies. The region benefits from a strong network of public and private healthcare institutions that are early adopters of advanced diagnostic solutions. Hospitals and diagnostic centers in South India have been quick to integrate molecular diagnostics for the early detection and monitoring of infectious diseases, cancer, and genetic disorders. This proactive approach has accelerated market growth by promoting awareness and accessibility among patients and healthcare providers.

South India has a growing base of skilled healthcare professionals and researchers, which supports the development and application of new diagnostic techniques. The region is also home to several medical and research institutions that collaborate with industry to drive innovation in diagnostics. The rise in medical tourism in cities like Chennai and Bengaluru has further spurred the demand for high-quality diagnostic services, including molecular diagnostics. Patients from across India and abroad seek treatment in these cities, increasing the need for rapid and accurate diagnostic solutions. However, the convergence of healthcare innovation, infrastructure development, and skilled talent makes South India the fastest growing region in the country's molecular diagnostics market, with strong potential for continued expansion.

Major companies operating in India Molecular Diagnostics Market are:

• Roche Diagnostics India Pvt Ltd
• Abbott India Ltd
• Qiagen India Pvt Ltd
• BioMérieux India Pvt Ltd
• Becton Dickinson Pvt Ltd
• Bio-Techne India Pvt Ltd
• Danaher India (DHR Holding India Pvt. Ltd.)
• Bio-Rad laboratories India Pvt.Ltd

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“India Molecular Diagnostics Market is experiencing impressive growth, driven by rising demand for early and accurate disease detection. The increasing prevalence of infectious diseases, cancer, and genetic disorders is fueling the adoption of advanced diagnostic technologies such as PCR and next-generation sequencing. Government support, improved healthcare infrastructure, and growing awareness of personalized medicine further boost market expansion. The shift toward point-of-care testing and localized manufacturing has enhanced accessibility and affordability. Also, increased investments from both public and private sectors are accelerating innovation. With these factors combined, India’s molecular diagnostics market is poised for sustained and significant growth in the coming years” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“India Molecular Diagnostics Market By Application (Infectious Disease, Blood Screening, Genetic Testing, Oncology Testing), By Technology (PCR, In-situ Hybridization, Chips and Microarrays, Mass Spectrometry, Sequencing, Others), By End User (Hospitals, Academic & Reference Laboratories), By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of India Molecular Diagnostics Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India Molecular Diagnostics Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com